Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

New Therapy Update

Azilsartan: A Newly Approved Angiotensin II Receptor Blocker

Lam, Sum PharmD

Author Information
doi: 10.1097/CRD.0b013e31822e9ba3
  • Buy

Abstract

© 2011 Lippincott Williams & Wilkins, Inc.